The Next 100 Years
Total Page:16
File Type:pdf, Size:1020Kb
“Instead of issues of population explosion or “… it’s in deep space that non-biological “By creating a Million-Member network excess-leisure, we may be collectively tackling ‘brains’ may develop powers that humans of engaged scientists and engineers we can the greatest challenge ever — survival — can’t even imagine.” p7 prove the power of collective action.” p30 at a cosmic scale of time and space.” p5 THE NEW YORK ACADEMY OF SCIENCES MAGAZINE • FALL 2017 THE NEXT 100 YEARS WWW.NYAS.ORG BOARD OF GOVERNORS CHAIR GOVERNORS Mehmood Khan, Vice Thomas Pompidou, Stefan Catsicas, Chief CHAIRS EMERITI Paul Horn, Senior Vice Jacqueline Corbelli, Chairman and Chief Sci- Founder and Partner Technology Officer John E. Sexton, Former Provost for Research, Chairman, CEO and entific Officer; Chairman at Marker LLC Nestlé S.A. President, New York New York University Co-Founder, BrightLine of Sustainability Council, Kathe Sackler, Founder Gerald Chan, Co-Founder, University Senior Vice Dean for Mikael Dolsten, Presi- PepsiCo and President, The Acorn Morningside Group Torsten N. Wiesel, Strategic Initiatives and dent, Worldwide Research Seema Kumar, Vice Foundation for the Arts & Alice P. Gast, President, Nobel Laureate & former Entrepreneurship, NYU and Development; Senior President of Innovation, Sciences Imperial College, London Secretary General, Human Polytechnic School of Vice President, Pfizer Inc Global Health and Science Frontier Science Program Mortimer D. A. Sackler, S. “Kris” Gopalakrishnan, Engineering Policy Communication for Organization; President MaryEllen Elia, New York Member of the Board, Chairman, Axilor Ven- Johnson & Johnson Emeritus, The Rockefeller VICE-CHAIR State Commissioner of Purdue Pharma tures/Co-founder Infosys Paul Walker, Technologist Education and President Pablo Legorreta, Founder University Peter Thorén, Executive Toni Hoover, Director and Philanthropist of the University of and CEO, Royalty Pharma Nancy Zimpher, Chan- Vice President, Access Strategy Planning and the State of New York cellor Emeritus, The State TREASURER David K.A. Mordecai, Industries Management and COO (USNY) University of New York Donna Milrod, Former RiskEcon® Decision Met- William Wachtel, Partner, for the Global Health (SUNY) Managing Director and Elaine Fuchs, Rebecca C. rics Lab/New York Uni- Wachtel Missry LLP Program, The Bill and Me- Lancefield Professor in versity, Courant Institute Head of DTCC Solutions, Grace Wang, Vice Chan- linda Gates Foundation HONORARY LIFE Mammalian Cell Biology of Mathematical Sciences Chairman of the Board of cellor for Research and Johan Rockström, GOVERNORS and Development, The & Stern Graduate School DTCC Deriv/SERV LLC Economic Development Executive Director of the Karen E. Burke, Derma- Rockefeller University; of Business and Chairman of the Om- for the State University of Stockholm Resilience tologist and Research Investigator, Howard geo Board of Managers Gregory A. Petsko, New York (SUNY) Centre, Chairman of the Scientist Hughes Medical Institute Professor of Neurology at PRESIDENT Michael Zigman, Presi- EAT Advisory Board John F. Niblack, Former Beth Jacobs, Managing Weill Cornell Medicine in Ellis Rubinstein, President dent and CEO, NYC FIRST Paul Stoffels, Chief President, Pfizer Global Partner of Excellentia New York City, and Tauber and CEO, The New York Scientific Officer, Johnson Research & Development Global Partners Professor of Biochemistry INTERNATIONAL Academy of Sciences & Johnson; member of and Chemistry, Emeritus, BOARD OF GOVERNORS John E. Kelly III, SVP, the Johnson & Johnson SECRETARY at Brandeis University in Seth F. Berkley, Chief Solutions Portfolio and Executive Committee & Larry Smith, The New Waltham, Massachusetts Executive Officer, The Research, IBM Management Committee; York Academy of Sciences Global Alliance for Vac- Worldwide Co-Chairman, cines and Immunization PRESIDENT’S COUNCIL Pharmaceuticals Group Peter Agre, Nobel Laureate; Thomas R. Cech, Nobel of Texas Southwestern versity; Investigator, HHMI Jeffrey D. Sachs, Special Craig B. Thompson, Univ. Prof. and Director, Laureate; Distinguished Prof., Medical Center Richard Menschel, Senior Advisor to the UN Secretary President and CEO, Johns Hopkins Malaria Re- University of S. “Kris” Gopalakrishnan, Director, Goldman Sachs General on the Sustain- Memorial Sloan Kettering search Inst., Dept. Molecular Colorado, Boulder able Development Goals Cancer Center Chairman, Axilor Ventures/ Ronay Menschel, Chairman Microbiology and Immunol- and Director of Center for Martin Chalfie, Nobel Co-founder Infosys of the Board, Phipps Houses; Shirley Tilghman, President ogy, Bloomberg School of Sustainable Development, Laureate; University Profes- Paul Greengard, Nobel Board of Overseers, Weill Emerita/Professor of Public Health Columbia University sor of Biological Sciences, Laureate; Prof. of Molecular Cornell Medical College Molecular Biology, Princeton Richard Axel, Nobel Lau- Columbia University Bengt Samuelsson, Nobel University & Cellular Neuroscience, The Ferid Murad, Nobel Laure- reate; University Professor, Laureate; Prof., Medical & Steven Chu, Nobel Laureate; Rockefeller University ate; Director, IMM Center for Frank Walsh, Chief Execu- Columbia Univ.; Investigator, Physiological Chem., Karo- William R. Kenan, Jr. Prof. of Glenda Greenwald, Cell Signaling, The University tive Officer, Ossianix, Inc. HHMI linska Inst.; Former Chair- Physics, Prof. of Molecular President, Aspen Brain of Texas at Houston George Whitesides, Wood- David Baltimore, Nobel and Cellular Physiology, man, The Nobel Foundation Forum Foundation John F. Niblack, Former ford L. & Ann A. Flowers Laureate; President Emeritus, Stanford University; Former Ismail Serageldin, Emeritus David Gross, Nobel Laure- President, Pfizer Global University Professor, Harvard Caltech U.S. Secretary of Energy Librarian of the Bibliotheca ate; Chancellor’s Chair Pro- Research & Development; University Alexandrina and member of Etienne-Emile Baulieu, Aaron J. Ciechanover, Nobel fessor of Theoretical Physics, Honorary Life Governor, The Torsten N. Wiesel, Nobel the Board of Trustees of the Former President, French Laureate; Distinguished Re- Kavli Institute for Theoreti- New York Academy Laureate; Chairman Emeri- library of Alexandria Academy of Sciences search Professor, Tumor and cal Physics, UCSB of Sciences tus, The New York Academy Vascular Biology Research Phillip A. Sharp, Nobel Laure- Paul Berg, Nobel Laureate; William A. Haseltine, Chair- Paul Nurse, Nobel Laureate; of Sciences; Former Secre- Center, Faculty of Medicine, ate; Director, The McGovern Professor Emeritus, Dept. man and President, ACCESS Former President, The Rocke- tary General, Human Frontier Technion-Israel Inst. of Tech., Institute, MIT Center for of Biochemistry, Stanford Health International, Inc. feller University; Former Science Program Organiza- University Haifa, Israel Cancer Research tion; President Emeritus, Hon. Jerry MacArthur President, The Royal Society, Kenneth L. Davis, President Feike Sijbesma, CEO/Chair- The Rockefeller Univ. Len Blavatnik, Chairman, Hultin, Senior Presidential London; Chief Executive, The and CEO of the Mount Sinai man of the Managing Board, Access Industries, Inc. Fellow, New York University; Francis Crick Institute Frank Wilczek, Nobel Health System in New York Royal DSM President Emeritus, Polytech- Yoshinori Ohsumi, Nobel Laureate; Herman Feshbach Günter Blobel, Nobel Laure- City ate; Director, Laboratory for nic Institute of NYU; former Laureate; Professor, Institute Michael Sohlman, Professor of Physics, Massa- Cell Biology, The Rockefeller Peter Doherty, Nobel Lau- Under Secretary of the Navy of Innovative Research, Tokyo Former Executive Director, chusetts Institute reate; Researcher, St. Jude The Nobel Foundation of Technology University Eric Kandel, Nobel Laureate; Institute of Technology (IIR) Children’s Research Hospital, Prof., Physiology & Cell Biolo- John O’Keefe, Nobel Laure- Paul Stoffels, Chief Scientific Ernst-Ludwig Winnacker, Irina Bokova, Director Gen- Memphis, Tennessee; Univ. eral, United Nations Educa- gy, Columbia University ate; Wellcome Trust Principal Officer, Johnson & Johnson; Secretary General, Human of Melbourne, Australia member of the Johnson Frontier Science Program Or- tional, Scientific and Cultural Roger Kornberg, Nobel Lau- Research Fellow and Prof. Organization (UNESCO) Mikael Dolsten, President, of Cognitive Neuroscience, & Johnson Executive Commit- ganization; Former Secretary Worldwide Research and reate; Professor of Medicine, tee & Management Commit- General, European Research Sydney Brenner, Nobel Stanford University Medical Sainsbury Wellcome Centre, Development; Senior University College London tee; Worldwide Co-Chairman, Council; Former President, Laureate; Distinguished Prof., Vice-President, Pfizer Inc School Pharmaceuticals Group Deutsche Forschungs- Salk Inst. Venkatraman Ramakrish- Jan Eliasson, Former Deputy Kiyoshi Kurokawa, Former Jack W. Szostak, Nobel gemeinschaft, Germany Michael S. Brown, Nobel Science Advisor to the Prime nan, Nobel Laureate; Presi- Secretary-General to the dent, The Royal Society Laureate; Investigator, Andrew Witty, Laureate; Prof. of Molecular United Nations Minister of Japan; Professor, Howard Hughes Medical Chancellor, University of Richard Roberts, Nobel Lau- Genetics, Univ. of Texas National Graduate Institute Institute; Professor of Genet- Nottingham UK; Former Edmond H. Fischer, Nobel reate; Chief Scientific Officer, Southwestern Medical for Policy Studies (GRIPS) ics,